Compare Abbott India with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs ALKEM LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA ALKEM LABORATORIES ABBOTT INDIA/
ALKEM LABORATORIES
 
P/E (TTM) x 50.8 21.5 236.2% View Chart
P/BV x 15.9 4.9 323.8% View Chart
Dividend Yield % 1.4 1.0 145.1%  

Financials

 ABBOTT INDIA   ALKEM LABORATORIES
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-21
ALKEM LABORATORIES
Mar-21
ABBOTT INDIA/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs18,5693,150 589.5%   
Low Rs13,9702,224 628.3%   
Sales per share (Unadj.) Rs2,028.2741.4 273.6%  
Earnings per share (Unadj.) Rs325.0135.3 240.2%  
Cash flow per share (Unadj.) Rs352.4158.3 222.7%  
Dividends per share (Unadj.) Rs275.0030.00 916.7%  
Avg Dividend yield %1.71.1 151.4%  
Book value per share (Unadj.) Rs1,203.7616.8 195.1%  
Shares outstanding (eoy) m21.25119.57 17.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x8.03.6 221.4%   
Avg P/E ratio x50.119.9 252.1%  
P/CF ratio (eoy) x46.217.0 272.0%  
Price / Book Value ratio x13.54.4 310.3%  
Dividend payout %84.622.2 381.6%   
Avg Mkt Cap Rs m345,717321,244 107.6%   
No. of employees `000NANA-   
Total wages/salary Rs m4,92716,210 30.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m43,10088,650 48.6%  
Other income Rs m8352,332 35.8%   
Total revenues Rs m43,93590,982 48.3%   
Gross profit Rs m9,18919,424 47.3%  
Depreciation Rs m5812,746 21.2%   
Interest Rs m183589 31.0%   
Profit before tax Rs m9,26018,421 50.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,3532,243 104.9%   
Profit after tax Rs m6,90716,178 42.7%  
Gross profit margin %21.321.9 97.3%  
Effective tax rate %25.412.2 208.6%   
Net profit margin %16.018.2 87.8%  
BALANCE SHEET DATA
Current assets Rs m35,18569,288 50.8%   
Current liabilities Rs m10,30936,041 28.6%   
Net working cap to sales %57.737.5 153.9%  
Current ratio x3.41.9 177.5%  
Inventory Days Days420 22.8%  
Debtors Days Days266 3.2%  
Net fixed assets Rs m3,04134,825 8.7%   
Share capital Rs m213239 88.9%   
"Free" reserves Rs m25,36673,517 34.5%   
Net worth Rs m25,57973,756 34.7%   
Long term debt Rs m0343 0.0%   
Total assets Rs m38,226104,114 36.7%  
Interest coverage x51.732.3 160.1%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.10.9 132.4%   
Return on assets %18.516.1 115.2%  
Return on equity %27.021.9 123.1%  
Return on capital %36.925.7 143.9%  
Exports to sales %0.722.1 3.1%   
Imports to sales %12.30-   
Exports (fob) Rs m29519,555 1.5%   
Imports (cif) Rs m5,306NA-   
Fx inflow Rs m35319,555 1.8%   
Fx outflow Rs m5,3892,467 218.4%   
Net fx Rs m-5,03517,088 -29.5%   
CASH FLOW
From Operations Rs m7,26712,649 57.5%  
From Investments Rs m-718-9,985 7.2%  
From Financial Activity Rs m-5,818-2,718 214.1%  
Net Cashflow Rs m731-17 -4,251.7%  

Share Holding

Indian Promoters % 0.0 57.1 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.7 19.6 39.6%  
FIIs % 0.2 5.4 4.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 42.9 58.3%  
Shareholders   90,567 81,869 110.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   SUN PHARMA    CIPLA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    



Today's Market

Sensex Ends 111 Points Lower, Nifty Holds 15,750; ONGC, Reliance Crash, while ITC & Bajaj Twins Gain 4%(Closing)

After opening the day deep in the red, Indian share markets slowly recovered most of their losses and ended on a flat note.

Related Views on News

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

More Views on News

Most Popular

Best Monopoly Stocks to Own in 2022(Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

The One Smallcap Stock I'll Recommend Now(Profit Hunter)

Jun 21, 2022

This aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.

Wait! Don't Buy the Smallcap 'Dip' Just Yet(Profit Hunter)

Jun 20, 2022

Why this may not be the best time to buy smallcaps.

5 Consistent Compounding Stocks Available at Discount. Time to Buy?(Views On News)

Jun 22, 2022

The good side of a market correction? Investors get consistent compounding stocks at a discount.

Looking for Value Stocks Amid Volatile Times? Consider These 5 Stocks(Views On News)

Jun 20, 2022

These value stocks have the potential to deliver good returns in the long run. Watch out for them.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jul 1, 2022 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - PFIZER COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS